{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:56:42Z","timestamp":1781744202780,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.mayocp.2025.08.020","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T12:27:08Z","timestamp":1769257628000},"page":"971-980","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pleuropulmonary Involvement in Erdheim\u2013Chester Disease"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2416-8054","authenticated-orcid":false,"given":"Steven","family":"Tessier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo A.","family":"Acosta-Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon T.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason R.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald S.","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay H.","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.mayocp.2025.08.020_bib1","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1038\/s41375-020-0944-4","article-title":"Erdheim-Chester disease: a rapidly evolving disease model","volume":"34","author":"Pegoraro","year":"2020","journal-title":"Leukemia"},{"issue":"13","key":"10.1016\/j.mayocp.2025.08.020_bib2","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2012-05-430140","article-title":"High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses","volume":"120","author":"Haroche","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.mayocp.2025.08.020_bib3","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/2159-8290.CD-15-0913","article-title":"Diverse and targetable kinase alterations drive histiocytic neoplasms","volume":"6","author":"Diamond","year":"2016","journal-title":"Cancer Discov"},{"issue":"6","key":"10.1016\/j.mayocp.2025.08.020_bib4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1182\/bloodadvances.2016001784","article-title":"The clinical spectrum of Erdheim-Chester disease: an observational cohort study","volume":"1","author":"Estrada-Veras","year":"2017","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.mayocp.2025.08.020_bib5","doi-asserted-by":"crossref","first-page":"E114","DOI":"10.1002\/ajh.25055","article-title":"Phenotypes and survival in Erdheim-Chester disease: results from a 165-patient cohort","volume":"93","author":"Cohen-Aubart","year":"2018","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.mayocp.2025.08.020_bib6","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/bjh.18422","article-title":"Classical and non-classical phenotypes of Erdheim-Chester disease: correlating clinical, radiographic and genotypic findings","volume":"199","author":"Hazim","year":"2022","journal-title":"Br J Haematol"},{"issue":"24","key":"10.1016\/j.mayocp.2025.08.020_bib7","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1182\/blood.2023021670","article-title":"Epidemiology and geographic clustering of Erdheim-Chester disease in Italy and France","volume":"142","author":"Peyronel","year":"2023","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.mayocp.2025.08.020_bib8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4132\/jptm.2017.10.16","article-title":"Erdheim-Chester disease involving lymph nodes and liver clinically mimicking lymphoma: a case report","volume":"52","author":"Sung","year":"2018","journal-title":"J Pathol Transl Med"},{"issue":"16","key":"10.1016\/j.mayocp.2025.08.020_bib9","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1182\/blood.2019002766","article-title":"Erdheim-Chester disease","volume":"135","author":"Haroche","year":"2020","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.mayocp.2025.08.020_bib10","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.3324\/haematol.2018.190728","article-title":"Prognostic factors of Erdheim-Chester disease: a nationwide survey in Japan","volume":"103","author":"Toya","year":"2018","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.mayocp.2025.08.020_bib11","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1002\/art.27672","article-title":"Pulmonary involvement in Erdheim-Chester disease: a single-center study of thirty-four patients and a review of the literature","volume":"62","author":"Arnaud","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.mayocp.2025.08.020_bib12","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/bjh.17712","article-title":"Pulmonary manifestations of Erdheim-Chester disease: clinical characteristics, outcomes and comparison with Langerhans cell histiocytosis","volume":"194","author":"Wang","year":"2021","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.mayocp.2025.08.020_bib13","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2214\/ajr.174.5.1741327","article-title":"Pulmonary involvement with Erdheim-Chester disease: radiographic and CT findings","volume":"174","author":"Wittenberg","year":"2000","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.mayocp.2025.08.020_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00000478-199901000-00002","article-title":"Erdheim-Chester disease: clinical, radiologic, and histopathologic findings in five patients with interstitial lung disease","volume":"23","author":"Egan","year":"1999","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.mayocp.2025.08.020_bib15","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.2214\/AJR.19.21523","article-title":"Multisystemic imaging findings in Chinese patients with Erdheim-Chester disease","volume":"213","author":"Wang","year":"2019","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"10.1016\/j.mayocp.2025.08.020_bib16","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2214\/ajr.183.5.1831253","article-title":"Imaging of thoracoabdominal involvement in Erdheim-Chester disease","volume":"183","author":"Dion","year":"2004","journal-title":"AJR Am J Roentgenol"},{"issue":"7","key":"10.1016\/j.mayocp.2025.08.020_bib17","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/modpathol.3880130","article-title":"Pulmonary pathology of Erdheim-Chester disease","volume":"13","author":"Rush","year":"2000","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.mayocp.2025.08.020_bib18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"22","key":"10.1016\/j.mayocp.2025.08.020_bib19","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1182\/blood.2019003507","article-title":"Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era","volume":"135","author":"Goyal","year":"2020","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.mayocp.2025.08.020_bib20","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1634\/theoncologist.2018-0295","article-title":"FDA approval summary: vemurafenib for the treatment of patients with Erdheim-Chester disease with the BRAFV600 mutation","volume":"23","author":"Oneal","year":"2018","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.mayocp.2025.08.020_bib21","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/jamaoncol.2017.5029","article-title":"Vemurafenib for BRAF V600-mutant Erdheim-Chester disease and Langerhans cell histiocytosis: analysis of data from the histology-independent, phase 2, open-label VE-BASKET study","volume":"4","author":"Diamond","year":"2018","journal-title":"JAMA Oncol"},{"issue":"11","key":"10.1016\/j.mayocp.2025.08.020_bib22","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1080\/10428194.2020.1783447","article-title":"Low-dose vemurafenib monotherapy in BRAFV600E -mutated Erdheim-Chester disease","volume":"61","author":"Ruan","year":"2020","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.mayocp.2025.08.020_bib23","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.3324\/haematol.2017.185298","article-title":"Single-agent dabrafenib for BRAFV600E-mutated histiocytosis","volume":"103","author":"Bhatia","year":"2018","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.mayocp.2025.08.020_bib24","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1200\/JCO.2014.57.1950","article-title":"Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim-Chester disease","volume":"33","author":"Haroche","year":"2015","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.mayocp.2025.08.020_bib25","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1182\/blood-2012-07-446286","article-title":"Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation","volume":"121","author":"Haroche","year":"2013","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.mayocp.2025.08.020_bib26","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00256-016-2431-6","article-title":"Erdheim Chester disease with appendicular skeletal, renal and pleural involvement responding to Zelboraf (BRAF inhibitor) treatment: case report","volume":"45","author":"Borys","year":"2016","journal-title":"Skeletal Radiol"},{"issue":"2","key":"10.1016\/j.mayocp.2025.08.020_bib27","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00277-023-05534-6","article-title":"Pulmonary Erdheim-Chester disease successfully treated with vemurafenib","volume":"103","author":"Shen","year":"2024","journal-title":"Ann Hematol"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619625004781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619625004781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:39:04Z","timestamp":1781743144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619625004781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0025619625004781"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2025.08.020","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pleuropulmonary Involvement in Erdheim\u2013Chester Disease","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2025.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}